Hogan Lovells berät NORD/LB bei der Finanzierung des Erwerbs von Scora Liquidity durch Maxburg
28. Mai 2026 – Unter der Leitung des Münchner Partners Dr. Thomas Freund und Counsel Peter Gierl hat die globale Wirtschaftskanzlei Hogan Lovells die Norddeutsche Landesbank – Girozentrale – bei der Finanzierung des Erwerbs der Scora Liquidity GmbH durch Maxburg Beteiligungen IV GmbH & Co. KG zu sämtlichen rechtlichen Aspekten beraten.
LIVE! enters the beauty market through the strategic acquisition of Pink Cheeks
LIVE!, a Brazilian company firmly established in the activewear segment, has taken a decisive step beyond its core business by acquiring a 60% stake in the skincare brand Pink Cheeks. The transaction, the company’s first acquisition, marks a clear repositioning—from an apparel-focused brand to an integrated wellness platform.
Martinelli Advogados strengthens its tax capabilities with the arrival of Herick Manardi
Martinelli Advogados has added Herick Manardi as a partner in its Santa Catarina office, reinforcing the firm’s tax practice with a profile that combines legal, accounting and financial expertise.
Martinelli Advogados strengthens its capabilities in business disputes and tax litigation with the arrival of new partners
Martinelli Advogados announces the addition of André Frossard Albuquerque and Sérgio Grama Lima to its partnership, a move that reinforces two areas increasingly critical for companies: the management of strategic disputes and tax litigation.
E+H advises MUST Visibility on financing round
E+H successfully advised MUST Visibility FlexCo, a deep-tech spin-off of Pro2Future GmbH, on the completion of a financing round. E+H has been advising the Graz-based startup since its founding in 2025.
Homburger advises Eli Lilly on the acquisition of LimmaTech Biologics
On May 26, 2026, Eli Lilly and Company (NYSE: LLY) announced the acquisition of LimmaTech Biologics AG for up to USD 780 m in cash, inclusive of an upfront payment and additional potential payments based upon the achievement of certain clinical and regulatory milestones. LimmaTech Biologics is developing vaccines against bacterial pathogens for which rising …
Continue reading “Homburger advises Eli Lilly on the acquisition of LimmaTech Biologics”
Hogan Lovells berät Banken bei der Platzierung von Green Bonds der Volkswagen Bank GmbH mit einem Emissionsvolumen von insgesamt EUR 2,75 Mrd.
27. Mai 2026 – Unter Leitung des Frankfurter Partners Dr. Jochen Seitz hat die globale Wirtschaftskanzlei Hogan Lovells ein Bankenkonsortium bestehend aus Banco Bilbao Vizcaya Argentaria, S.A, BNP PARIBAS, Citigroup Global Markets Europe AG, Commerzbank AG und SMBC Bank EU AG bei der Platzierung von drei Green Bonds der Volkswagen Bank GmbH mit einem Emissionsvolumen von …
Changes under Bill C-15 affecting the Bank Act
Written by:Eric Belli-BivarNella Garofalo As consumer fraud continues to rise across Canada, the federal government is moving to strengthen protections in the financial sector through the Budget 2025 Implementation Act, No. 1 (Bill C-15). Bill C-15 amends the Bank Act to establish new requirements to combat “consumer-targeted fraud”, including policies for banks to address fraud …
Continue reading “Changes under Bill C-15 affecting the Bank Act”
From market risk to political risk: The new reality of board oversight
Boards face new risks as political decisions, not markets, reshape global business oversight Boards have always understood market volatility. Interest rates move, currencies swing, and commodity prices rise and fall. What has evolved is not the existence of risk, but its source. Presently, some of the most decisive threats to enterprise value arise not from …
Continue reading “From market risk to political risk: The new reality of board oversight”
Resilience amid uncertainty: 2025 Canadian capital markets review
Written by:Derek SigelDesron HarryThaarane Sethunathan (Articling Student) On February 12, 2026, the Canadian Securities Administrators (CSA) published its 2025 Systemic Risk Committee Annual Report on Capital Markets (Annual Report). The Annual Report is issued annually by the CSA’s Systemic Risk Committee to assess key risks and emerging trends affecting Canadian capital markets and to provide guidance for …
Continue reading “Resilience amid uncertainty: 2025 Canadian capital markets review”